Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Pharma-Factory

Financiado

Cerrado

Building the product pipeline for commercial demonstration of Plant Molecular Fa...

Building the product pipeline for commercial demonstration of Plant Molecular Factories Plant Molecular Farming is the manufacture of high-value products using plant biotechnology. Pharma-Factory was conceived and designed by SMEs active in the field to produce medical, veterinary and diagnostic products. Product-dri... ver más

31/08/2022

ST GEORGES HOSPITA...

9M€

Presupuesto del proyecto: 9M€

Líder del proyecto

ST GEORGES HOSPITAL MEDICAL SCHOOL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 15 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-08-31

BB-07-2017: Plant Molecular Factory

I+D

Cerrada hace 8 años

0% 90% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

15 Participantes

ST GEORGES HOSPITAL MEDICAL...

1.62M€ | Lider

CRATUS HISPANIA

LEAF SYSTEMS INTERNATIONAL L...

384.04K€ | Participante

SAMABRIVA

455.70K€ | Participante

Proyectos interesantes

Kyron.bio WomenTech

Medical Technol...

Biotechnology

75K€ Cerrado

BIO2017-82084-ERC

Medical Technol...

Biotechnology

68K€ Cerrado

PCI2018-093066

Medical Technol...

Biotechnology

197K€ Cerrado

SYNBIOMAN

Biotechnology

Medical Technol...

71K€ Cerrado

TRIGEM

Medical Technol...

Biotechnology

183K€ Cerrado

PCIN-2016-190

Medical Technol...

Biotechnology

100K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 58 meses Fecha Inicio: 2017-10-06
Fecha Fin: 2022-08-31

Líder del proyecto

ST GEORGES HOSPITAL MEDICAL SCHOOL No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 9M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Plant Molecular Farming is the manufacture of high-value products using plant biotechnology. Pharma-Factory was conceived and designed by SMEs active in the field to produce medical, veterinary and diagnostic products. Product-driven work packages and a collective approach to public involvement and regulatory consultation will accelerate commercialisation of new bio-products, and increase the competitiveness of European bio-industry by resolving technical, social and economic bottlenecks in this field. All parts of the work programme are addressed by refining technologies using new synthetic biology tools, demonstrating manufacturing advantages for individual products, identifying a clear regulatory path for each platform technology, developing clear business cases with supporting techno-economic evaluations and life cycle analyses and improving public engagement and acceptance. Five SMEs will develop products that include arylsulfatase B (for human enzyme replacement therapy), a vaccine for infectious spleen and kidney necrosis virus in fish, two highly potent HIV neutralising antibody-based fusion proteins and plant chimaeric virus-like-particles for a diagnostic kit. In collaboration with academic partners they will advance six plant molecular farming platforms for this purpose, including whole plants, algae, hairy roots and plant cell culture, by designing and developing new tools to increase the competitiveness, utility and versatility of each platform. All companies will reach Technology Readiness Level 5 within the lifetime of the project, with two products to be commercialized. The project provides a unique opportunity to improve public involvement with plant biotechnology at a European-wide level. A work package has been dedicated to gain maximal impact by engaging with all stakeholders – from scientists to government and the public at large, developing new tools to facilitate communication, to help understand and reduce barriers to acceptance.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores